Literature DB >> 15292339

Impaired activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 in cultured preadipocyte-derived adipocytes and myotubes of obese subjects.

M P Sajan1, M L Standaert, A Miura, G Bandyopadhyay, P Vollenweider, D M Franklin, R Lea-Currie, R V Farese.   

Abstract

Insulin resistance in obesity is partly due to diminished glucose transport in myocytes and adipocytes, but underlying mechanisms are uncertain. Insulin-stimulated glucose transport requires activation of phosphatidylinositol (PI) 3-kinase (3K), operating downstream of insulin receptor substrate-1. PI3K stimulates glucose transport through increases in PI-3,4,5-(PO(4))(3) (PIP(3)), which activates atypical protein kinase C (aPKC) and protein kinase B (PKB/Akt). However, previous studies suggest that activation of aPKC, but not PKB, is impaired in intact muscles and cultured myocytes of obese subjects. Presently, we examined insulin activation of glucose transport and signaling factors in cultured adipocytes derived from preadipocytes harvested during elective liposuction in lean and obese women. Relative to adipocytes of lean women, insulin-stimulated [(3)H]2-deoxyglucose uptake and activation of insulin receptor substrate-1/PI3K and aPKCs, but not PKB, were diminished in adipocytes of obese women. Additionally, the direct activation of aPKCs by PIP(3) in vitro was diminished in aPKCs isolated from adipocytes of obese women. Similar impairment in aPKC activation by PIP(3) was observed in cultured myocytes of obese glucose-intolerant subjects. These findings suggest the presence of defects in PI3K and aPKC activation that persist in cultured cells and limit insulin-stimulated glucose transport in adipocytes and myocytes of obese subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292339     DOI: 10.1210/jc.2004-0106

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.

Authors:  V Luna; L Casauban; M P Sajan; J Gomez-Daspet; J L Powe; A Miura; J Rivas; M L Standaert; R V Farese
Journal:  Diabetologia       Date:  2006-01-05       Impact factor: 10.122

2.  Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humans.

Authors:  L Casaubon; M P Sajan; J Rivas; J L Powe; M L Standaert; R V Farese
Journal:  Diabetologia       Date:  2006-10-07       Impact factor: 10.122

Review 3.  Metabolic functions of atypical protein kinase C: "good" and "bad" as defined by nutritional status.

Authors:  Robert V Farese; Mini P Sajan
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-08       Impact factor: 4.310

4.  Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.

Authors:  F Andreozzi; C Procopio; A Greco; G C Mannino; C Miele; G A Raciti; C Iadicicco; F Beguinot; A E Pontiroli; M L Hribal; F Folli; G Sesti
Journal:  Diabetologia       Date:  2011-04-01       Impact factor: 10.122

5.  Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: peroxisome proliferator-activated receptor gamma agonist improves defective activation of atypical protein kinase C.

Authors:  Heidi K Ortmeyer; Mini P Sajan; Atsushi Miura; Yoshinore Kanoh; Jose Rivas; Yongxiang Li; Mary L Standaert; Alice S Ryan; Noni L Bodkin; Robert V Farese; Barbara C Hansen
Journal:  Antioxid Redox Signal       Date:  2010-11-23       Impact factor: 8.401

6.  Requirements for pseudosubstrate arginine residues during autoinhibition and phosphatidylinositol 3,4,5-(PO₄)₃-dependent activation of atypical PKC.

Authors:  Robert A Ivey; Mini P Sajan; Robert V Farese
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

7.  Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells.

Authors:  Cora Weigert; Matthias Kron; Hubert Kalbacher; Ann Kathrin Pohl; Heike Runge; Hans-Ulrich Häring; Erwin Schleicher; Rainer Lehmann
Journal:  Mol Endocrinol       Date:  2008-10-16

8.  Protein kinase Cζ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation.

Authors:  Irene S Tobias; Manuel Kaulich; Peter K Kim; Nitya Simon; Estela Jacinto; Steven F Dowdy; Charles C King; Alexandra C Newton
Journal:  Biochem J       Date:  2015-12-03       Impact factor: 3.857

9.  Protein kinase Czeta mediates insulin-induced glucose transport through actin remodeling in L6 muscle cells.

Authors:  Li-Zhong Liu; Hai-Lu Zhao; Jin Zuo; Stanley K S Ho; Juliana C N Chan; Yan Meng; Fu-De Fang; Peter C Y Tong
Journal:  Mol Biol Cell       Date:  2006-03-08       Impact factor: 4.138

10.  Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum.

Authors:  Jacob E Friedman; John P Kirwan; Ming Jing; Larraine Presley; Patrick M Catalano
Journal:  Diabetes       Date:  2007-12-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.